$LMAT
LEMAITRE VASCULAR INC

2017 Q1 Form 10-Q Financial Statement

#000119312517157833 Filed on May 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $24.14M $20.26M
YoY Change 19.16% 6.92%
Cost Of Revenue $6.786M $5.902M
YoY Change 14.98% 1.23%
Gross Profit $17.35M $14.36M
YoY Change 20.88% 9.45%
Gross Profit Margin 71.89% 70.87%
Selling, General & Admin $11.50M $9.610M
YoY Change 19.69% 1.42%
% of Gross Profit 66.28% 66.94%
Research & Development $1.658M $1.446M
YoY Change 14.66% 25.52%
% of Gross Profit 9.55% 10.07%
Depreciation & Amortization $979.0K $881.0K
YoY Change 11.12% 5.89%
% of Gross Profit 5.64% 6.14%
Operating Expenses $13.16M $11.06M
YoY Change 19.03% 2.29%
Operating Profit $4.193M $3.300M
YoY Change 27.06% 42.92%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net
YoY Change
Pretax Income $4.239M $3.265M
YoY Change 29.83% 40.37%
Income Tax $1.020M $1.099M
% Of Pretax Income 24.06% 33.66%
Net Earnings $3.219M $2.166M
YoY Change 48.61% 58.22%
Net Earnings / Revenue 13.34% 10.69%
Basic Earnings Per Share $0.17 $0.12
Diluted Earnings Per Share $0.16 $0.11
COMMON SHARES
Basic Shares Outstanding 18.63M shares 18.34M shares
Diluted Shares Outstanding 19.71M shares 18.86M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.80M $25.90M
YoY Change -0.39% 52.35%
Cash & Equivalents $25.81M $25.94M
Short-Term Investments
Other Short-Term Assets $4.700M $2.900M
YoY Change 62.07% 20.83%
Inventory $20.60M $17.90M
Prepaid Expenses
Receivables $14.09M $13.02M
Other Receivables $0.00 $0.00
Total Short-Term Assets $62.50M $59.74M
YoY Change 4.62% 24.99%
LONG-TERM ASSETS
Property, Plant & Equipment $9.279M $7.355M
YoY Change 26.16% 11.54%
Goodwill $23.63M $18.19M
YoY Change 29.89% 6.19%
Intangibles $9.524M $6.660M
YoY Change 43.0% 0.62%
Long-Term Investments
YoY Change
Other Assets $165.0K $170.0K
YoY Change -2.94% 1.19%
Total Long-Term Assets $44.02M $33.64M
YoY Change 30.84% 5.87%
TOTAL ASSETS
Total Short-Term Assets $62.50M $59.74M
Total Long-Term Assets $44.02M $33.64M
Total Assets $106.5M $93.38M
YoY Change 14.07% 17.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.220M $1.773M
YoY Change 25.21% 57.18%
Accrued Expenses $8.286M $7.668M
YoY Change 8.06% 27.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.77M $10.16M
YoY Change 5.91% 21.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.198M $916.0K
YoY Change 139.96% 168.62%
Total Long-Term Liabilities $2.198M $916.0K
YoY Change 139.96% 168.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.77M $10.16M
Total Long-Term Liabilities $2.198M $916.0K
Total Liabilities $14.90M $12.76M
YoY Change 16.8% 9.57%
SHAREHOLDERS EQUITY
Retained Earnings $17.53M $9.502M
YoY Change 84.45% 142.58%
Common Stock $202.0K $198.0K
YoY Change 2.02% 4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.830M $8.519M
YoY Change 3.65% 3.15%
Treasury Stock Shares 1.453B shares 1.431M shares
Shareholders Equity $91.62M $80.62M
YoY Change
Total Liabilities & Shareholders Equity $106.5M $93.38M
YoY Change 14.07% 17.36%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $3.219M $2.166M
YoY Change 48.61% 58.22%
Depreciation, Depletion And Amortization $979.0K $881.0K
YoY Change 11.12% 5.89%
Cash From Operating Activities $2.480M $1.260M
YoY Change 96.83% -310.0%
INVESTING ACTIVITIES
Capital Expenditures -$1.690M $720.0K
YoY Change -334.72% 122.91%
Acquisitions $2.382M
YoY Change 1626.09%
Other Investing Activities -$2.380M
YoY Change 1600.0%
Cash From Investing Activities -$1.690M -$3.100M
YoY Change -45.48% 573.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $819.0K $141.0K
YoY Change 480.85% -144.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 560.0K 140.0K
YoY Change 300.0% -136.84%
NET CHANGE
Cash From Operating Activities 2.480M 1.260M
Cash From Investing Activities -1.690M -3.100M
Cash From Financing Activities 560.0K 140.0K
Net Change In Cash 1.350M -1.700M
YoY Change -179.41% 18.06%
FREE CASH FLOW
Cash From Operating Activities $2.480M $1.260M
Capital Expenditures -$1.690M $720.0K
Free Cash Flow $4.170M $540.0K
YoY Change 672.22% -158.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18809313 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25941000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3655000
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19021000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20155198 shares
CY2017Q1 us-gaap Assets
Assets
106522000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1124000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1407000
CY2017Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
210000
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
422000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
62504000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37000000 shares
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
271000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25810000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
926000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14090000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
202000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1307000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2220000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
713000
CY2017Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
148000
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86683000
CY2017Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
1029000
CY2017Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
1402000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3963000
CY2017Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1421000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1941000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8286000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9497000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11757000
CY2017Q1 us-gaap Other Inventory Capitalized Costs
OtherInventoryCapitalizedCosts
2708000
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9524000
CY2017Q1 us-gaap Inventory Net
InventoryNet
20596000
CY2017Q1 us-gaap Liabilities
Liabilities
14904000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106522000
CY2017Q1 us-gaap Goodwill
Goodwill
23629000
CY2017Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2968000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2198000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10765000
CY2017Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
164000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2302000
CY2017Q1 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
1100000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
165000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1573000
CY2017Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3163000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9279000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
91618000
CY2017Q1 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
3900000
CY2017Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1152000
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
407000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17526000
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1452810000 shares
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2008000
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
8830000
CY2017Q1 lmat Acquisition Related Obligations
AcquisitionRelatedObligations
259000
CY2017Q1 lmat Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
20596000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27451000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6124000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18886000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
394000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
59027000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20040348 shares
CY2016Q4 us-gaap Assets
Assets
101924000
CY2016Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
200000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37000000 shares
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
258000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24288000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
200000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2810000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13191000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1217000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
122000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85378000
CY2016Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
1253000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4583000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1399000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1941000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8804000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8989000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11662000
CY2016Q4 us-gaap Other Inventory Capitalized Costs
OtherInventoryCapitalizedCosts
2617000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9897000
CY2016Q4 us-gaap Inventory Net
InventoryNet
19578000
CY2016Q4 us-gaap Liabilities
Liabilities
14424000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101924000
CY2016Q4 us-gaap Goodwill
Goodwill
23426000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2489000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2001000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10482000
CY2016Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
154000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2246000
CY2016Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
1100000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8012000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
87500000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
312000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15335000
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1452810000 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1970000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8830000
CY2016Q4 lmat Acquisition Related Obligations
AcquisitionRelatedObligations
461000
CY2016Q4 lmat Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
19578000
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
LEMAITRE VASCULAR INC
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
200000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001158895
CY2017Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y10M24D
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1522000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
178000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
487000
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.055
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4548000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
454000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6786000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
979000
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3839000
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26000
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
620000
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
51000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
24139000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-367000
CY2017Q1 us-gaap Gross Profit
GrossProfit
17353000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
13160000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
3219000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4239000
CY2017Q1 us-gaap Interest Expense
InterestExpense
0
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1691000
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
137000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
858000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
620000
CY2017Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
113000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1102000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4193000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
559000
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
275000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1020000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2476000
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
819000
CY2017Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
90000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19707000 shares
CY2017Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1076000 shares
CY2017Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2017Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
17000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18631000 shares
CY2017Q1 dei Trading Symbol
TradingSymbol
LMAT
CY2017Q1 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1658000
CY2017Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
115000 shares
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6954000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
487000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20000 shares
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1510000
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2017Q1 lmat Statute Of Limitation Expiration Period
StatuteOfLimitationExpirationPeriod
2025
CY2017Q1 lmat Provision For Doubtful Accounts And Sales Allowances
ProvisionForDoubtfulAccountsAndSalesAllowances
48000
CY2017Q1 lmat Payments To Acquire Property Plant Equipment And Other Assets
PaymentsToAcquirePropertyPlantEquipmentAndOtherAssets
1691000
CY2017Q1 lmat Purchase Commitments Inventory Expire Year
PurchaseCommitmentsInventoryExpireYear
2018
CY2017Q1 lmat Payments Related To Acquisitions
PaymentsRelatedToAcquisitions
260000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
193000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
330000
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.045
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3337000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
881000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3095000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
380000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5902000
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50000
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
20258000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1821000
CY2016Q1 us-gaap Gross Profit
GrossProfit
14356000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
11056000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
2166000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3265000
CY2016Q1 us-gaap Interest Expense
InterestExpense
0
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3102000
CY2016Q1 lmat Provision For Doubtful Accounts And Sales Allowances
ProvisionForDoubtfulAccountsAndSalesAllowances
52000
CY2016Q1 lmat Payments To Acquire Property Plant Equipment And Other Assets
PaymentsToAcquirePropertyPlantEquipmentAndOtherAssets
720000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6273000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
330000
CY2016Q1 us-gaap Inventory Write Down
InventoryWriteDown
36000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
825000
CY2016Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2382000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-827000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
929000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
392000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3300000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
141000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
108000
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
929000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1099000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1258000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
141000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18860000 shares
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
524000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18336000 shares
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1446000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
23000 shares

Files In Submission

Name View Source Status
0001193125-17-157833-index-headers.html Edgar Link pending
0001193125-17-157833-index.html Edgar Link pending
0001193125-17-157833.txt Edgar Link pending
0001193125-17-157833-xbrl.zip Edgar Link pending
d368417d10q.htm Edgar Link pending
d368417dex311.htm Edgar Link pending
d368417dex312.htm Edgar Link pending
d368417dex321.htm Edgar Link pending
d368417dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lmat-20170331.xml Edgar Link completed
lmat-20170331.xsd Edgar Link pending
lmat-20170331_cal.xml Edgar Link unprocessable
lmat-20170331_def.xml Edgar Link unprocessable
lmat-20170331_lab.xml Edgar Link unprocessable
lmat-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending